Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer.
about
Haplotype analysis suggest common founders in carriers of the recurrent BRCA2mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer familiesBRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.Germline truncating mutations in both MSH2 and BRCA2 in a single kindred.
P2860
Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Prevalence of founder BRCA1 an ...... dian women with breast cancer.
@en
Prevalence of founder BRCA1 an ...... dian women with breast cancer.
@nl
type
label
Prevalence of founder BRCA1 an ...... dian women with breast cancer.
@en
Prevalence of founder BRCA1 an ...... dian women with breast cancer.
@nl
prefLabel
Prevalence of founder BRCA1 an ...... dian women with breast cancer.
@en
Prevalence of founder BRCA1 an ...... dian women with breast cancer.
@nl
P2093
P2860
P1433
P1476
Prevalence of founder BRCA1 an ...... dian women with breast cancer.
@en
P2093
Chappuis PO
Deschênes J
Ghadirian P
Paradis AJ
Robidoux A
P2860
P304
P356
10.1034/J.1399-0004.2001.590606.X
P577
2001-06-01T00:00:00Z